These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5994826)

  • 41. [Hemostimulating properties of cropanol during cytostatics-induced myelosuppression].
    Zhdanov VV; Gol'dberg VE; Khrichkova TIu; Matiash MG; Gur'iantseva LA; Simolina EI; Vysotskaia VV; Suslov NI; Popova NO; Dygaĭ AM
    Eksp Klin Farmakol; 2002; 65(6):37-40. PubMed ID: 12596531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.
    Bergsagel DE; Robertson GL; Hasselback R
    Can Med Assoc J; 1968 Mar; 98(11):532-8. PubMed ID: 5643297
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma.
    Fried W; Kedo A; Barone J
    Cancer Res; 1977 Apr; 37(4):1205-9. PubMed ID: 321118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of recombinant human tumor necrosis factor-alpha, alone and in combination with cyclophosphamide or methotrexate, on leukemia L1210 and normal hematopoiesis in mice.
    Warzocha K; Robak T; Korycka A; Graczyk J; Pakulska W; Gałazka G; Kłysik J
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):587-95. PubMed ID: 1841555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hematopoietic response after treatment with cyclophosphamide and autotransplantation of non-damaged bone marrow cells.
    Ninkov V; Piletić O
    Acta Biol Med Ger; 1974; 33(1):35-41. PubMed ID: 4609244
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of cyclophosphamide on neuroblastoma and the bone marrow function in the experimental studies].
    Ohkawa M
    Hokkaido Igaku Zasshi; 1983 Nov; 58(6):561-74. PubMed ID: 6368346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experiences with intense cytostatic therapy of malignant tumors].
    Siering H; Reinhardt M
    Arzneimittelforschung; 1968 Sep; 18(9):1182-91. PubMed ID: 4885374
    [No Abstract]   [Full Text] [Related]  

  • 48. Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapy.
    Zimmerman TM; Mick R; Myers S; Bender JG; Lee WJ; Williams SF
    Bone Marrow Transplant; 1995 Jun; 15(6):923-7. PubMed ID: 7581092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the spleen in cyclophosphamide-induced hematosuppression and extramedullary hematopoiesis in mice.
    Wang Y; Meng Q; Qiao H; Jiang H; Sun X
    Arch Med Res; 2009 May; 40(4):249-55. PubMed ID: 19608013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The rate of cyclophosphamide activation.
    Syrkin AB; Zaitzeva LA
    Neoplasma; 1970; 17(4):377-81. PubMed ID: 5506443
    [No Abstract]   [Full Text] [Related]  

  • 51. Maitake beta-glucan enhances granulopoiesis and mobilization of granulocytes by increasing G-CSF production and modulating CXCR4/SDF-1 expression.
    Ito K; Masuda Y; Yamasaki Y; Yokota Y; Nanba H
    Int Immunopharmacol; 2009 Sep; 9(10):1189-96. PubMed ID: 19573626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Perspectives of use of polymer carriers of epidoxorubicin and cyclophosphamide in cancer therapy].
    Zółtowska K; Sobczak M
    Polim Med; 2014; 44(1):51-62. PubMed ID: 24918656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid and complete reconstitution of autologous haemopoiesis after cord blood infusion in treatment-naive patients with severe aplastic anemia receiving high-dose cyclophosphamide/ATG therapy.
    Li Y; Sheng Z; Niu S; Ge L; Ren C; Zou Y
    Eur J Haematol; 2013 Jan; 90(1):45-50. PubMed ID: 23106334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of cyclophosphamide on the bone marrow hematopoiesis in the mouse].
    Xie RF
    Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):435-7. PubMed ID: 3836845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Do anabolic steroids protect bone marrow during cytostatic therapy?].
    Kopera H
    Med Klin; 1980 Jul; 75(15):539-43. PubMed ID: 7001201
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of disulfiram on cyclophosphamide toxicity: a clinical trial.
    Ershler WB; Hacker MP; Newman RA; Stewart JA; Gamelli RL; Krakoff IH
    Cancer Treat Rep; 1983 Dec; 67(12):1145-7. PubMed ID: 6652633
    [No Abstract]   [Full Text] [Related]  

  • 57. [Comparative studies of the effects of the antitumor agents on growth and hematopoiesis of mature and immature rabbits].
    Kaneko N
    Nihon Ika Daigaku Zasshi; 1970; 37(1):45-59. PubMed ID: 5441009
    [No Abstract]   [Full Text] [Related]  

  • 58. Source of stem cell rescue: bone marrow versus peripheral blood progenitors.
    Williams SF; Zimmerman T; Grad G; Mick R
    J Hematother; 1993; 2(4):521-3. PubMed ID: 7522110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of cyclophosphamide on the blood and bone marrow of the guinea-pig.
    Kaul M; Hudson G
    J Anat; 1969 Jan; 104(Pt 1):190. PubMed ID: 5779563
    [No Abstract]   [Full Text] [Related]  

  • 60. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies.
    Koumakis G; Vassilomanolakis M; Hatzichristou H; Barbounis V; Filis J; Papanastasiou K; Moraki M; Kritsioti M; Plataniotis G; Stamatelou M; Efremidis AP
    Bone Marrow Transplant; 1996 Dec; 18(6):1065-72. PubMed ID: 8971374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.